arrow
V

Vincenzo Myftari

sapienza university of rome
H指数:7
被引数:194

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Vericiguat therapy reduces arrhythmic events in heart failure patients with cardiac implantable electronic devices

维利西呱治疗可降低植入式心脏电子设备患者心力衰竭中的心律失常事件

2026-07-070
OAAI
Intrarenal venous flow improvement after vericiguat in worsening HFrEF: A prospective VExUS-based study

维利卡格他治疗加重的心衰伴射血分数降低后肾内静脉血流改善:一项前瞻性基于VExUS的研究

2026-07-011
PRE
Early SGLT2i Therapy Facilitates In-Hospital ARNI Introduction Improving 6-Month Systolic Function in Patients with HFrEF

早期SGLT2i疗法有助于促进住院期间ARNI的引入,改善HFrEF患者6个月时的收缩功能

2025-10-060
OA
Coronary microcirculation in myocardial ischemia: A genetic perspective

心肌缺血中的冠状动脉微循环:一个遗传学视角

2025-06-010
PRE
Early in-hospital use of SGLT2i in heart failure patients with ischemic etiology

缺血性病因心力衰竭患者早期院内使用SGLT2i

2025-05-150
OA
The Role of High-Sensitivity Troponin T Regarding Prognosis and Cardiovascular Outcome across Heart Failure Spectrum
2024-06-170
OAAI
Prognostic Assessment of HLM Score in Heart Failure Due to Ischemic Heart Disease: A Pilot Study

HLM评分对缺血性心脏病心力衰竭的预后评估: 一项初步研究

2024-06-043
OAAI